Cancer patients must speak to doctors before taking weight-loss jabs
Cancer patients must speak to their doctor before taking weight-loss jabs, a charity has warned, amid a rise in people seeking help over whether they can take them.
Macmillan Cancer Support said while 'quick fixes' may seem appealing, there is currently not enough evidence over how the drugs might affect anti-cancer treatments.
It said more research is needed but it was already known the drugs may affect how other medicines are absorbed by the body. This may include some anti-cancer drugs, it said.
Dr Owen Carter, national clinical adviser at Macmillan Cancer Support, said: 'Recently we have seen a noticeable increase in calls to Macmillan's free support line and a flurry of messages on our peer-to-peer online community about weight-loss drugs.
'We know that cancer affects everybody differently and it's understandable that lots of people are interested in new drugs which accelerate weight loss, particularly if they want to manage their weight before or after treatment for cancer.
'While 'quick fixes' may seem attractive, we simply do not know enough about the long-term impact of these weight-loss medications to recommend them if they're not prescribed by a specialist.
'Additionally, certain weight loss medications carry warnings about a potential link with thyroid cancer.
'However, we know that eating well and staying as active as possible are proven to help people feel better, increase their energy levels and strengthen their immune systems, which can help them to manage their weight and cope better with cancer treatment.
'If you have questions about cancer, including about weight-loss drugs, we urge you to speak to your GP or call the Macmillan support line.
'Trusted advisers are available 8am-8pm, seven days a week, to provide callers with information and support, or just a listening ear.'
Macmillan said it has now published new information on its website about the drugs and cancer.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Two Leeds hospitals' maternity services rated inadequate over safety risks
The care of women and babies at two Leeds hospitals presents a significant risk to their safety, the NHS regulator has said, after the preventable deaths of dozens of newborns. The Care Quality Commission (CQC) demanded urgent improvements to maternity services at Leeds general infirmary and St James's hospital as it downgraded them to 'inadequate'. A BBC investigation this year found that the deaths of at least 56 babies and two mothers may have been preventable at the two hospitals between January 2019 and July 2024. The hospitals, run by Leeds teaching hospitals NHS trust, are the latest to be engulfed by a maternity scandal that has revealed catastrophic failings in Nottingham, Shrewsbury and Telford, Morecambe Bay, east Kent and others. The downgrading of maternity and neonatal services in Leeds follows unannounced inspections by the CQC in December and January. Ann Ford, a director of operations at the CQC, said it had received concerns from staff, patients and families about safety and staffing levels at the two hospitals. She said: 'During the inspection the concerns were substantiated, and this posed a significant risk to the safety of women, people using these services, and their babies as the staff shortages impacted on the timeliness of the care and support they received.' Inspectors found dirty areas on the maternity wards of both hospitals, unsafe storage of medicines, a 'blame culture' that left staff unwilling to raise concerns, and short-staffed units. On the neonatal wards, which care for the most vulnerable newborns, the CQC found they were understaffed and infants needing special care were being transported unsafely from one hospital to another. A freedom of information request by the BBC revealed in January that the NHS trust had identified at least 56 baby deaths that may have been preventable from January 2019 to July 2024, made up of 27 stillbirths and 29 neonatal deaths, which are deaths within 28 days after birth. In each case, a trust review group had identified care issues it considered may have made a difference to the outcome for babies. Sir Julian Hartley, the head of the CQC, was the chief executive of Leeds teaching hospitals NHS trust for 10 years until January 2023, meaning he was in charge when many of the preventable deaths took place. The parents of a newborn girl who died after multiple failings at Leeds general infirmary in January 2020 questioned the CQC's ability to carry out an independent inspection, given Hartley's previous role. The regulator said it has 'robust policies in place to manage any conflict of interest'. Prof Phil Wood, the chief executive of Leeds teaching hospitals NHS trust, said: 'These reports have highlighted significant areas where we need to improve our maternity and neonatal services, and my priority is to make sure we urgently take action to deliver these improvements.' He said the trust was improving whistleblowing procedures for staff and had recruited 55 midwives, leaving it 11 short of the national target. Wood added: 'I want to reassure every family due to have their baby with us in Leeds and any new parents that we are absolutely committed to providing safe, compassionate care.'
Sky News
an hour ago
- Sky News
Assisted dying bill set for crunch vote after months of debate over controversial legislation
Why you can trust Sky News A controversial bill which would give some terminally ill adults the right to end their lives is facing a crunch vote in the Commons today. The Terminally Ill Adults (End of Life) Bill, more commonly known as the assisted dying bill, will be back for its third reading, which is the first time MPs will vote on the overall piece of legislation since the yes vote in November. That vote, during the bill's second reading, saw MPs vote 330 to 275 to approve the bill - a relatively narrow majority which means every vote will count later. If the new amendments are voted through, the bill to give some terminally ill adults the right to end their lives will get closer to becoming law as it will go through to the next stage in the House of Lords. Speaking at a news conference on Thursday, Labour MP Kim Leadbeater, who introduced the assisted dying bill in October last year, said she felt confident the vote will be successful. She said: "There might be some small movement in the middle, some people might change their mind or will change their mind the other way. Ms Leadbeater said if MPs fail to vote the legislation through, "it could be another decade before this issue is brought back to parliament". She added: "It works and it is safe, and it provides dignity to terminally ill people. "This is not an either or when it comes to palliative care or assisted dying. It is about choice for people." But on the eve of the vote, four Labour MPs confirmed they were switching their vote from yes to no as they branded the bill "drastically weakened", citing the scrapping of the High Court Judge safeguard as a key reason. Ms Leadbeater has insisted the replacement of High Court judge approval with the multidisciplinary panels is a strengthening of the legislation, incorporating wider expert knowledge to assess assisted dying applications. The proposed legislation would allow terminally ill adults, with fewer than six months to live, to apply for an assisted death, subject to approval by two doctors and a panel featuring a social worker, senior legal figure and psychiatrist. A new YouGov poll found 72% of Britons supported the bill as it stands, including 59% of those who say they support assisted dying in principle but oppose it in practice, and 67% were opposed to the principle of euthanasia but are willing to back it in practice. Recently, the Royal College of Psychiatrists (RCP), the Royal College of Pathologists and the Royal College of Physicians have raised concerns about the bill. The RCP said the bill, in its current form, did "not meet the needs of patients". It has also expressed concern over the shortage of qualified psychiatrists to take part in assisted dying panels.
Daily Mail
3 hours ago
- Daily Mail
Strange sign in earwax may predict if you'll get brain disorder that affects 10million
That gross, waxy stuff in your ears could actually say a lot about your health. Researchers in China have identified key differences in the makeup of earwax in people with Parkinson's disease compared to people without the condition, suggesting the sticky stuff holds secrets that could flag a person's risk of eventually developing the condition. Scientists at Zhejiang University took earwax samples from 100 people with Parkinson's and 79 without. They chose earwax because much of it is made up of sebum, an oily substance that undergoes chemical changes in cases of Parkinson's, and releases distinct volatile organic compounds (VOCs). Parkinson's triggers neurodegeneration, inflammation, and oxidative stress, altering sebum's composition and creating a distinct odor. It also progressively damages the brain, causing tremors, stiffness, and slow movement. Over time, symptoms worsen to include sudden freezing, speech loss, swallowing problems — often leading to pneumonia — and falls, both common causes of death among people with Parkinson's. Four specific types of VOCs stood out among people with the condition, suggesting that earwax could potentially be an accessible indicator of Parkinson's, which would allow patients to avoid invasive diagnostic tests and spinal taps. Around 1million Americans and 10million people globally currently have the disease, with nearly 90,000 new cases diagnosed each year. As that number is projected to climb, early diagnosis is more important than ever. While there is no cure, medication regimens can be started early to treat symptoms and slow down the progression of the disease. Researchers fed the VOC data from the samples of earwax into an algorithm that categorized subjects' Parkinson's status accurately 94 percent of the time, demonstrating the potential for a fast, reliable diagnostic tool. The VOCs that stood out to researchers were all significant in differentiating between people with the condition and those without it, even after accounting for age and lifestyle factors. Two of the VOCS, Ethylbenzene & 4-Ethyltoluene, are compounds commonly found in plastics and petroleum products. Their presence suggests inflammation in the brain, which is a key driver of the breakdown of dopamine in the brain. Dopamine, while often thought of as a 'feel good' neurotransmitter, is a key chemical messenger that regulates movement control. As dopamine levels plummet while Parkinson's progresses, people become steadily more immobile. Another significant VOC was Pentanal, which is produced when fats break down. Elevated levels suggest cell damage, a hallmark of Parkinson's. The compound has been linked to an accumulation of protein clumps in patients' brains. And the VOC 2-Pentadecyl-1,3-dioxolane likely reflects issues with the metabolism of fats, which could have originated from microbiome changes in the skin of patients. It's unclear whether this VOC has any direct links to PD, but there is an expanding body of research pointing to a connection between PD and an imbalance in the gut microbiome. Research suggests that VOCs are produced by the balance of good bacteria in the gut, which have also been associated with brain health. An imbalance that allows harmful bacteria to flourish, leading to a proliferation of toxins that can cause inflammation in the brain. VOCs come from a wide array of toxic sources in the environment, from pesticides used to grow food, industrial chemicals in gasoline, and solvents in everyday items like dry cleaning chemicals and adhesives, to cleaning products, car emissions, and contaminated groundwater. Parkinson's is believed to be caused by a confluence of genetic and environmental factors. It is the world's fastest-growing brain disorder, and, according to NIH research, 'exposure to environmental toxicants is the principal reason.' In the US, deaths from Parkinson's disease have more than doubled in the past 20 years, with about 35,000 deaths in 2019 compared to 14,500 in 1999. Parkinson's death rates rose from 42 to 65 deaths per 100,000 from 1999–2017 While considering the clues that earwax can provide about Parkinson's development is new, investigating the role that VOCs play is not. A sweeping 2023 meta-analysis identified distinct VOCs present in the breath and skin oil in people with the disease compared to those without it. These compounds are specifically linked with oxidative stress, or a barrage of damage that cells endure before dying. Dr Hao Dong, a co-researcher on the recent study, said: 'This method is a small-scale single-center experiment in China. 'The next step is to conduct further research at different stages of the disease, in multiple research centers and among multiple ethnic groups, in order to determine whether this method has greater practical application value.'
